April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Retina-specific Dna Methylation
Author Affiliations & Notes
  • Mariam S. Assadian
    Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland
  • Verity F. Oliver
    Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland
  • Kieron Torres
    Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland
  • Ray A. Enke
    Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland
  • Shannath L. Merbs
    Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland
  • Footnotes
    Commercial Relationships  Mariam S. Assadian, None; Verity F. Oliver, None; Kieron Torres, None; Ray A. Enke, None; Shannath L. Merbs, None
  • Footnotes
    Support  NIH R21EY018703
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 5984. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Mariam S. Assadian, Verity F. Oliver, Kieron Torres, Ray A. Enke, Shannath L. Merbs; Retina-specific Dna Methylation. Invest. Ophthalmol. Vis. Sci. 2011;52(14):5984.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : DNA methylation is known to play a critical role in the differentiation of cells and tissues, and changes in DNA methylation have been shown to be important in the development of some diseases. We have previously demonstrated that certain retina-specific genes, including Rho and Rbp3, are differentially hypomethylated in the retina when compared to non-expressing tissues in the mouse. We believe that a genome-wide DNA methylation map of the retina will be invaluable as we search to understand the role of DNA methylation in retinal development and disease.

Methods: : Whole retinas were extruded from 3 C57B/6J mice at 2 months of age. Mouse cortex was isolated as non-retinal control tissue. Genomic DNA was isolated and fragmented to an average of 300 bp. The fragmented DNA was divided in to 2 fractions: input DNA and a second fraction that was enriched for methylated DNA using MethylCollector (ActiveMotif). Enrichment was confirmed by QPCR of Rho, which is relatively unmethylated in the retina and methylated in the brain. The input DNA and methylated fractions were subjected to whole genome amplification (WGA), and maintenance of the enrichment was confirmed by QPCR, prior to being labeled and hybridized to mouse CHARM arrays (Comprehensive High-throughput Analysis of Relative Methylation, NimbleGen).

Results: : Multiple techniques for WGA were compared to insure that we were using the technique that best maintained our methylated DNA enrichment. The enriched and labeled DNAs are currently being evaluated in our ongoing, genome-wide analysis using the CHARM array. Retina-specific DNA methylation sites (when compared to brain) will be compared to known tissue-differentially methylated regions that have previously been identified by CHARM in other tissues.

Conclusions: : Our pangenomic characterization of retina-specific DNA patterns provides an important resource for future studies to investigate the relationship between DNA methylation and retinal development and disease.

Keywords: gene microarray • retina 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×